AyuVis Research, Inc. Email Format
Biotechnology ResearchTexas, United States2-10 Employees
AyuVis Research, Inc. is a small biotechnology company based in Fort Worth, Texas, focused on developing New Molecular Entities that modulate the innate immune system. Its drug candidates aim to influence macrophages to restore balance between infection control and inflammation, potentially delivering rapid therapeutic effects by stimulating phagocytosis. The company holds two patents granted by the USPTO covering compositions of matter, methods of use, and formulations related to its compounds. The lead candidate has FDA designations as both an Orphan Drug and Rare Pediatric Disease for preventing bronchopulmonary dysplasia in at-risk preterm infants. AyuVis is pursuing a generation of immunotherapies, including AVR-48, to achieve a well-balanced immune response that addresses both infection and inflammation. It collaborates with the University of North Texas Health Science Center in Fort Worth through its incubator program.